Regulatory Roundup: ICH Steering Committee Approves Revised Guideline for Genotoxicity Testing and Data Interpretation for Medicines
The International Conference on Harmonization (ICH) steering committee and working groups met in Seville, Spain, earlier this month. The groups meet twice annually to discuss, revise, and approve various harmonization guidelines. At the latest meeting, the steering committee approved a revised ICH S2(R1) guideline for genotoxicity testing and data interpretation for medicines intended for human use. The Quality Implementation Working Group (IWG) completed three points-to-consider documents on process validation/process verification, the role of modeling in QbD, and design space. All documents will soon appear on the ICH website. The next meeting will be held in Fukuoka, Japan, in June 2012.
The US Pharmacopeia has developed a memorandum of understanding with the Chilean Pharmacopeia Foundation to help provide the quality and safety of medicines in Chile and the United States. USP has recently established similar partnerships with Russia and the Ukraine.
Columnists
Outsourcing
Commercializing Cell Therapies: Lonza’s Eytan Abraham on Challenges and Rewards
Better equipment and automated processes will be key. So, too, will the right way of approaching outsourcing relationships.
Tech Ops for Hire
As CMOs shed their old toll processing role, sponsors can expect the right questions, proactive communication, and a firm grasp of risk management and tech transfer from contract service providers.
Webcasts
- Enhancing Quality and Process Efficiency Using Continuous Manufacturing Technology for Drug Substance and Drug Product
- Safe and Cost-Effective Capsule Filling for Pre-Clinical and First-in-Man Studies
- Maximizing Roller Compaction Benefits with Proper Excipient Selection
- Developing a Comprehensive Tool Kit for Microbial Identification
Sponsored Links
